InVasc Therapeutics' Grant

InVasc Therapeutics raised a round of funding on May 14, 2010. Investors include National Institutes of Health.

InVasc Therapeutics specializes in target-specific drug discovery and has developed a approach to drug discovery that uses molecular structures and an application-based platform that decreases the ti…

Articles about InVasc Therapeutics' Grant: